Search

everythinglearnresearchcommunity

for

Search:↓

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Minoxidil foam 5% effectively treats hair loss in both frontal and vertex scalp regions.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Apoptosis contributes to hair loss in androgenetic alopecia.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

Low-dose oral minoxidil improves hair growth in male hair loss.

Combining platelet-rich plasma with 5% minoxidil solution improves hair regrowth in androgenetic alopecia patients.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Alopecia causes smaller hair follicles and affects growth-related structures.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.